Wednesday, July 25, 2018

A transatlantic trade war is brewing. Can it be stopped?

Europe is hoping crunch talks with the United States next week will head off the threat of car tariffs and a transatlantic trade war.

But expectations for the meeting between President Donald Trump and European Commission President Jean-Claude Juncker could hardly be lower.

"Anything short of an outright disaster would be considered a success," Judith Lee, an international trade lawyer at Gibson Dunn, said of the talks scheduled for Wednesday in Washington.

The United States has put tariffs on aluminum and steel imports from the European Union, and the bloc has retaliated with new taxes on American products. Trump is now threatening to hike tariffs on cars and auto parts from the European Union to 20%.

EU trade commissioner Cecilia Malmstr枚m, who is also making the trip to the United States, said the purpose of the trip was to lower the temperature.

"The aim of President Juncker's visit is to try to establish a good [relationship], try to see how we can deescalate the situation ... and see if there's a forum where we can discuss these issues," Malmstr枚m said on Thursday.

The United States and European Union have the world's largest bilateral trading relationship, worth over $1.1 trillion a year. But some analysts say that Trump will continue to chip away at the vital business link.

"Everybody expects Trump to carry on imposing more tariffs," said David Henig, a trade expert and director at the European Centre for International Political Economy.

Trump has not adopted a conciliatory stance ahead of the meeting, tweeting his reaction this week to an EU antitrust ruling that went against Google (GOOGL).

"I told you so! The European Union just slapped a Five Billion Dollar fine on one of our great companies, Google. They truly have taken advantage of the U.S., but not for long!" he said on Twitter.

I told you so! The European Union just slapped a Five Billion Dollar fine on one of our great companies, Google. They truly have taken advantage of the U.S., but not for long!

— Donald J. Trump (@realDonaldTrump) July 19, 2018

On Friday, he accused Europe (and China) of keeping their currencies artificially weak while the dollar strengthened, "taking away our big competitive edge."

'I don't know if it would work'

Top White House economic adviser Larry Kudlow said Wednesday he expects Juncker to bring a "very important free trade offer."

But it's unclear whether the European Union will be able to offer concessions that would satisfy Trump. The bloc would be looking for the United States to make concessions as part of any deal.

The European Union charges a 10% tariff on cars imported from the United States. But 85% of cars assembled in the United States and sold in Europe are exempted because they contain European parts. The United States charges a 2.5% tax on cars imported from Europe.

Malmstr枚m said Thursday that the bloc would consider "outside the box" solutions including an effort to coordinate with other major auto-producing nations to lower tariffs on cars produced in the United States.

"It is one idea of many. I don't know if it would work at all," she said.

GFX juncker trump eu us Juncker is meeting Trump at the White House on Wednesday.

The United States has already turned down an EU offer to slash its car tariffs during talks over the steel and aluminum tariffs, and analysts have warned that offering further concessions could have negative consequences.

"As soon as we give in ... on cars, he'll smell blood in the water and move on to the next [thing]," said Ross Denton, a trade expert and partner at Baker & McKenzie in London.

'Beyond economic rationalities'

Trump has framed his trade actions as part of an effort to shrink the US trade deficit and boost its exports.

About 35% of the US trade deficit is attributable to auto imports, according to analysts at UBS. The European Union, which is home to Volkswagen (VLKAY), BMW (BMWYY) and Mercedes owner Daimler (DDAIF), exports over ��50 billion ($58 billion) in cars and auto parts to the United States each year.

But analysts say that lower tariffs would do little to shift the trade balance.

"Americans love European cars... Do Europeans like American cars, generally? Not so much," said Denton.

Carsten Nickel, a research director at Teneo Intelligence, said that lower car tariffs might please Trump, but they probably wouldn't translate into any real economic benefit.

"The story here goes beyond economic rationalities," he said.

Malmstr枚m said that work is already underway on a list of American products that would be hit if Trump moves ahead with the car tariffs.

The bloc warned earlier this month that nearly $300 billion of US exports could be hit by retaliatory tariffs if the Trump administration decides to penalize automobile imports from around the world.

Saturday, July 21, 2018

Top 10 Low Price Stocks To Watch Right Now

tags:CVU,RADA,OFC,NTTHF,C,PETM,NAO,BBDO,HLIT,GPC, The price of wine is going up.

Global wine production slumped to its lowest level in 60 years in 2017, according to data from the International Organisation of Vine and Wine.

The most recent harvest produced 25 billion liters of wine, a decrease from 26.7 billion in 2016 and 27.6 billion in 2015. The decline was driven by weak harvests in key markets including Europe and South Africa.

The shortage has caused the wholesale price of basic wine in Italy to skyrocket 74% over the previous year, according to the European Commission. Prices are up 45% in Spain and over 10% in France.

Analysts said that producers, dealers and retailers will absorb some of the price hikes, but consumers will end up paying more -- especially for cheaper bottles.

"The wine companies that are targeting very low prices ... will be hit the worst, because their margins are very low," said Stephen Rannekleiv, a global beverages strategist at Rabobank. "When prices go up, it puts a lot of strain on them."

Top 10 Low Price Stocks To Watch Right Now: CPI Aerostructures, Inc.(CVU)

Advisors' Opinion:
  • [By Ethan Ryder]

    Penn Capital Management Co. Inc. lessened its holdings in shares of CPI Aero (NYSEAMERICAN:CVU) by 22.5% in the 1st quarter, Holdings Channel reports. The firm owned 253,588 shares of the aerospace company’s stock after selling 73,720 shares during the quarter. Penn Capital Management Co. Inc.’s holdings in CPI Aero were worth $2,472,000 as of its most recent filing with the SEC.

  • [By Lisa Levin]

    CPI Aerostructures, Inc. (NYSE: CVU) is estimated to report quarterly earnings at $0.1 per share on revenue of $18.50 million.

    SORL Auto Parts, Inc. (NASDAQ: SORL) is expected to report quarterly earnings at $0.19 per share on revenue of $86.96 million.

Top 10 Low Price Stocks To Watch Right Now: Rada Electronics Industries Limited(RADA)

Advisors' Opinion:
  • [By Logan Wallace]

    TESSCO Technologies (NASDAQ: TESS) and RADA Electronic Industries (NASDAQ:RADA) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings.

Top 10 Low Price Stocks To Watch Right Now: Corporate Office Properties Trust(OFC)

Advisors' Opinion:
  • [By Logan Wallace]

    Media headlines about Corporate Office Properties Trust (NYSE:OFC) have been trending somewhat positive on Sunday, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Corporate Office Properties Trust earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned news headlines about the real estate investment trust an impact score of 45.8310227240563 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Shane Hupp]

    A.R.T. Advisors LLC cut its position in Corporate Office Properties Trust (NYSE:OFC) by 30.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 95,700 shares of the real estate investment trust’s stock after selling 41,800 shares during the quarter. A.R.T. Advisors LLC owned approximately 0.09% of Corporate Office Properties Trust worth $2,471,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Corporate Office Properties Trust (NYSE:OFC) CEO Stephen E. Budorick bought 526 shares of Corporate Office Properties Trust stock in a transaction dated Thursday, June 28th. The stock was acquired at an average cost of $28.34 per share, for a total transaction of $14,906.84. Following the purchase, the chief executive officer now directly owns 105,368 shares in the company, valued at approximately $2,986,129.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Stephan Byrd]

    Barclays PLC grew its holdings in shares of Corporate Office Properties Trust (NYSE:OFC) by 20.5% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 244,725 shares of the real estate investment trust’s stock after buying an additional 41,577 shares during the quarter. Barclays PLC owned 0.24% of Corporate Office Properties Trust worth $6,321,000 at the end of the most recent reporting period.

Top 10 Low Price Stocks To Watch Right Now: Neo Lithium Corp. (NTTHF)

Advisors' Opinion:
  • [By ]

    The following 6 companies are on the bench for the index:

    Advantage Lithium (OTCQX:AVLIF) Argosy Minerals (OTCPK:ARYMF) Bacanora Minerals (OTC:BCRMF) Critical Elements (OTCQX:CRECF) NEO Lithium (OTCQX:NTTHF) Wealth Minerals (OTCQX:WMLLF)

    "Bench" is a sports analogy meaning that one or more of them could be added in the future if one of the above companies becomes a producer, is acquired, or the market capitalization ("cap") of one or more of the index holdings falls significantly below that of one or more companies on the bench.

  • [By ]

    Other juniors include: Advantage Lithium (OTCQB:AVLIF) [TSXV:AAL], AIS Resources [TSXV:AIS] (OTCQB:AISSF), American Lithium Corp. [TSX-V: LI] (OTCQB:LIACF), Argentina Lithium and Energy Corp. [TSXV:LIT] (OTCQB:PNXLF), Argosy Minerals [ASX:AGY] (OTC:ARYMF), AVZ Minerals [ASX:AVZ] (OTC:AZZVF), Bacanora Minerals [TSXV:BCN] [AIM:BCN] [GR:1BQ] (OTC:BCRMF), Birimian Ltd [ASX:BGS] (OTC:EEYMF), Critical Elements [TSXV:CRE] [GR:F12] (OTCQX:CRECF), Dajin Resources [TSXV:DJI] (OTCPK:DJIFF), Enigri (private), Eramet (EN Paris:ERA) (OTCPK:ERMAY), European Metals Holdings [ASX:EMH] [AIM:EMH] [GR:E861] (OTC:ERPNF), Far Resources [CSE:FAT] (OTCPK:FRRSF), Force Commodities [ASX:4CE], Kidman Resources [ASX:KDR] [GR:6KR], Latin Resources Ltd [ASX: LRS] (OTC:LAXXF), Lithium Australia [ASX:LIT] (OTC:LMMFF), Lithium Power International [ASX:LPI] (OTC:LTHHF), LSC Lithium [TSXV:LSC] (OTC:LSSCF), MetalsTech [ASX:MTC], MGX Minerals [CSE:XMG] (OTC:MGXMF), Millennial Lithium Corp. [TSXV:ML] (OTCQB:MLNLF), Neo Lithium [TSXV:NLC] (OTC:NTTHF), NRG Metals Inc. [TSXV:NGZ] (OTCQB:NRGMF), Nemaska Lithium [TSX:NMX] [GR:NOT] (OTCQX:NMKEF), North American Lithium (private), Piedmont Lithium [ASX:PLL] (OTC:PLLLY), Prospect Resources [ASX:PSC], Sayona Mining [ASX:SYA] (OTCPK:DMNXF), Savannah Resources [LSE:SAV], Standard Lithium [TSXV:SLL] (OTC:STLHF), and Wealth Minerals [TSXV:WML] (OTCQB:WMLLF).

Top 10 Low Price Stocks To Watch Right Now: Citigroup Inc.(C)

Advisors' Opinion:
  • [By Ethan Ryder]

    Miles Capital Inc. increased its holdings in shares of Citigroup (NYSE:C) by 36.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,728 shares of the financial services provider’s stock after acquiring an additional 1,811 shares during the period. Miles Capital Inc.’s holdings in Citigroup were worth $454,000 at the end of the most recent reporting period.

  • [By ]

    Wells Fargo Securities analyst Mike Mayo is wondering who will replace Citigroup (C) Chairman Michael O'Neill, who is set for mandatory retirement at the end of 2018.

  • [By ]

    JPMorgan Chase & Co. (JPM) , Citigroup Inc. (C) and Wells Fargo & Co. (WFC) each reported strong earnings beats Friday, April 13, kicking off what analysts expect to be a solid quarter for the sector.

  • [By ]

    TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer was pleased with the financial results from JPMorgan Chase (JPM) and Citigroup (C) .

Top 10 Low Price Stocks To Watch Right Now: PetSmart Inc(PETM)

Advisors' Opinion:
  • [By Shane Hupp]

    An issue of PetSmart, Inc. (NASDAQ:PETM) debt rose 1% against its face value during trading on Monday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $67.50 and was trading at $66.25 last week. Price moves in a company’s debt in credit markets often anticipate parallel moves in its share price.

  • [By Joseph Griffin]

    An issue of PetSmart, Inc. (NASDAQ:PETM) bonds fell 1.6% as a percentage of their face value during trading on Wednesday. The high-yield debt issue has a 8.875% coupon and is set to mature on June 1, 2025. The debt is now trading at $49.19 and was trading at $55.47 one week ago. Price changes in a company’s bonds in credit markets often predict parallel changes in its stock price.

Top 10 Low Price Stocks To Watch Right Now: Nordic American Offshore Ltd(NAO)

Advisors' Opinion:
  • [By Stephan Byrd]

    Media headlines about Nordic American Offshore (NYSE:NAO) have been trending somewhat negative on Thursday, according to Accern. Accern ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Nordic American Offshore earned a media sentiment score of -0.10 on Accern’s scale. Accern also assigned headlines about the shipping company an impact score of 46.9955270541452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Max Byerly]

    Nordic American Offshore (NYSE: NAO) and DryShips (NASDAQ:DRYS) are both small-cap transportation companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk.

Top 10 Low Price Stocks To Watch Right Now: Banco Bradesco Sa(BBDO)

Advisors' Opinion:
  • [By Ethan Ryder]

    News articles about Banco Bradesco (NYSE:BBDO) have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Banco Bradesco earned a news impact score of 0.19 on Accern’s scale. Accern also gave news stories about the bank an impact score of 46.8086143489448 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top 10 Low Price Stocks To Watch Right Now: Harmonic Inc.(HLIT)

Advisors' Opinion:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Harmonic (HLIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Harmonic (HLIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Harmonic Inc. (NASDAQ:HLIT) has been assigned an average recommendation of “Hold” from the eight research firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $5.33.

Top 10 Low Price Stocks To Watch Right Now: Genuine Parts Company(GPC)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Genuine Parts (GPC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Genuine Parts (GPC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Bruderman Asset Management LLC lessened its stake in shares of Genuine Parts (NYSE:GPC) by 37.9% in the 1st quarter, Holdings Channel reports. The firm owned 4,091 shares of the specialty retailer’s stock after selling 2,495 shares during the quarter. Bruderman Asset Management LLC’s holdings in Genuine Parts were worth $368,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    DekaBank Deutsche Girozentrale lessened its position in shares of Genuine Parts (NYSE:GPC) by 64.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,092 shares of the specialty retailer’s stock after selling 19,733 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Genuine Parts were worth $1,065,000 at the end of the most recent reporting period.

Friday, July 20, 2018

Brokerages Set Xylem Inc (XYL) PT at $79.78

Xylem Inc (NYSE:XYL) has been assigned an average recommendation of “Buy” from the twelve brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $79.78.

A number of equities research analysts recently weighed in on the company. Zacks Investment Research upgraded Xylem from a “hold” rating to a “buy” rating and set a $88.00 price target on the stock in a report on Tuesday, March 20th. Boenning Scattergood restated a “buy” rating and issued a $90.00 price target on shares of Xylem in a report on Tuesday, May 1st. BMO Capital Markets lowered their price target on Xylem from $86.00 to $83.00 and set an “outperform” rating on the stock in a report on Wednesday, May 2nd. Oppenheimer restated a “buy” rating and issued a $82.00 price target on shares of Xylem in a report on Tuesday, May 1st. Finally, Canaccord Genuity set a $78.00 price target on Xylem and gave the stock a “hold” rating in a report on Tuesday, April 24th.

Get Xylem alerts:

In other Xylem news, Director Curtis J. Crawford sold 7,500 shares of the stock in a transaction on Monday, May 14th. The stock was sold at an average price of $73.39, for a total transaction of $550,425.00. Following the sale, the director now owns 41,744 shares in the company, valued at approximately $3,063,592.16. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.81% of the stock is currently owned by corporate insiders.

A number of large investors have recently made changes to their positions in the business. Baillie Gifford & Co. grew its holdings in Xylem by 19.0% during the 2nd quarter. Baillie Gifford & Co. now owns 48,518 shares of the industrial products company’s stock valued at $3,269,000 after buying an additional 7,748 shares during the last quarter. Smithfield Trust Co. lifted its stake in shares of Xylem by 1,690.0% during the 2nd quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock worth $108,000 after purchasing an additional 1,521 shares during the period. Rathbone Brothers plc lifted its stake in shares of Xylem by 99.7% during the 2nd quarter. Rathbone Brothers plc now owns 95,350 shares of the industrial products company’s stock worth $6,425,000 after purchasing an additional 47,605 shares during the period. Atria Investments LLC purchased a new position in shares of Xylem during the 2nd quarter worth $571,000. Finally, Daiwa SB Investments Ltd. lifted its stake in shares of Xylem by 192.2% during the 2nd quarter. Daiwa SB Investments Ltd. now owns 59,657 shares of the industrial products company’s stock worth $4,020,000 after purchasing an additional 39,242 shares during the period. Hedge funds and other institutional investors own 82.99% of the company’s stock.

XYL opened at $67.80 on Friday. The company has a market capitalization of $12.33 billion, a P/E ratio of 28.25, a PEG ratio of 1.32 and a beta of 1.09. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.02 and a current ratio of 1.42. Xylem has a 1-year low of $56.18 and a 1-year high of $79.83.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, May 1st. The industrial products company reported $0.51 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.51. The business had revenue of $1.22 billion for the quarter, compared to analysts’ expectations of $1.19 billion. Xylem had a return on equity of 18.31% and a net margin of 7.29%. The company’s revenue was up 13.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 EPS. equities research analysts forecast that Xylem will post 2.89 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Thursday, June 21st. Shareholders of record on Thursday, May 24th were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date was Wednesday, May 23rd. Xylem’s dividend payout ratio (DPR) is presently 35.00%.

About Xylem

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Featured Story: What does EPS mean?

Analyst Recommendations for Xylem (NYSE:XYL)

Friday, July 13, 2018

Banyan Network (BBN) 24-Hour Trading Volume Reaches $1.36 Million

Banyan Network (CURRENCY:BBN) traded down 13.5% against the US dollar during the twenty-four hour period ending at 0:00 AM ET on July 11th. In the last week, Banyan Network has traded 26.1% lower against the US dollar. One Banyan Network token can now be purchased for $0.0267 or 0.00000421 BTC on exchanges including IDEX and Bibox. Banyan Network has a total market capitalization of $7.82 million and $1.36 million worth of Banyan Network was traded on exchanges in the last day.

Here’s how other cryptocurrencies have performed in the last day:

Get Banyan Network alerts: Electroneum (ETN) traded 2.7% higher against the dollar and now trades at $0.0113 or 0.00000178 BTC. Ripio Credit Network (RCN) traded up 1.6% against the dollar and now trades at $0.0435 or 0.00000685 BTC. Elastic (XEL) traded 8.6% lower against the dollar and now trades at $0.13 or 0.00002012 BTC. Bismuth (BIS) traded 1% lower against the dollar and now trades at $1.02 or 0.00016094 BTC. Origin Sport (ORS) traded down 2.5% against the dollar and now trades at $0.13 or 0.00002005 BTC. Golos (GOLOS) traded 1.2% higher against the dollar and now trades at $0.0345 or 0.00000544 BTC. Vezt (VZT) traded 2.6% higher against the dollar and now trades at $0.0514 or 0.00000811 BTC. Woodcoin (LOG) traded flat against the dollar and now trades at $0.10 or 0.00001588 BTC. Bytecent (BYC) traded down 2.7% against the dollar and now trades at $0.37 or 0.00005765 BTC. OctoCoin (888) traded 2.6% higher against the dollar and now trades at $0.0022 or 0.00000035 BTC.

Banyan Network Profile

Banyan Network (CRYPTO:BBN) uses the hashing algorithm. It launched on January 20th, 2018. Banyan Network’s total supply is 1,000,000,000 tokens and its circulating supply is 292,873,734 tokens. Banyan Network’s official Twitter account is @banyan_network. The official website for Banyan Network is www.banyanbbt.org. The Reddit community for Banyan Network is /r/BanyanNetwork.

Banyan Network Token Trading

Banyan Network can be traded on these cryptocurrency exchanges: IDEX and Bibox. It is usually not possible to purchase alternative cryptocurrencies such as Banyan Network directly using U.S. dollars. Investors seeking to trade Banyan Network should first purchase Ethereum or Bitcoin using an exchange that deals in U.S. dollars such as GDAX, Changelly or Gemini. Investors can then use their newly-acquired Ethereum or Bitcoin to purchase Banyan Network using one of the exchanges listed above.

Thursday, July 12, 2018

Vina Concha y Toro (VCO) Downgraded to “Hold” at ValuEngine

ValuEngine downgraded shares of Vina Concha y Toro (NYSE:VCO) from a buy rating to a hold rating in a research report released on Wednesday.

Shares of Vina Concha y Toro opened at $41.40 on Wednesday, Marketbeat Ratings reports. Vina Concha y Toro has a 12 month low of $31.45 and a 12 month high of $47.99. The company has a current ratio of 1.87, a quick ratio of 1.03 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $1.56 billion, a price-to-earnings ratio of 19.08 and a beta of 0.27.

Get Vina Concha y Toro alerts:

Vina Concha y Toro (NYSE:VCO) last issued its quarterly earnings data on Tuesday, May 22nd. The company reported $0.29 EPS for the quarter. The firm had revenue of $206.57 million for the quarter. Vina Concha y Toro had a net margin of 8.13% and a return on equity of 9.59%.

Several institutional investors have recently modified their holdings of the company. Dimensional Fund Advisors LP raised its stake in shares of Vina Concha y Toro by 5.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 35,950 shares of the company’s stock valued at $1,528,000 after purchasing an additional 1,902 shares in the last quarter. Castleark Management LLC acquired a new stake in shares of Vina Concha y Toro in the 4th quarter valued at about $148,000. Finally, Schafer Cullen Capital Management Inc. raised its stake in shares of Vina Concha y Toro by 15.7% in the 4th quarter. Schafer Cullen Capital Management Inc. now owns 162,764 shares of the company’s stock valued at $5,933,000 after purchasing an additional 22,135 shares in the last quarter. Institutional investors and hedge funds own 1.33% of the company’s stock.

About Vina Concha y Toro

Vi帽a Concha y Toro SA, together with its subsidiaries, produces and distributes wines in Chile. It operates through two segments, Wines and Other. The company sells its premium wines under the Don Melchor, Carm铆n de Peumo, Gravas del Maipo, Amelia, Terrunyo, Marqu茅s de Casa Concha, Gran Reserva Serie Riberas, Casillero del Diablo, Trio, and Late Harvest brand names; varietal and bi-varietal wines under the Sunrise, Concha y Toro, and Frontera brands; and popular wines under the Tocornal, Clos de Pirque, Exportacion, and Fressco brand names.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Wednesday, July 11, 2018

3 Reasons MoviePass Stock Is No Sirius XM Radio

Things are getting pretty dire in the world of�Helios and Matheson Analytics�(NASDAQ:HMNY), the reeling parent company of the MoviePass multiplex subscription service. The stock has surrendered 97% of its value in 2018, and there doesn't seem to be an easy way out.

Optimists may want to look at Sirius XM Radio (NASDAQ:SIRI) for inspiration at this point. Helios and Matheson may be trading for pocket change now, but Sirius XM stock bottomed out at $0.05 in early 2009, and there other similarities beyond the penny stock pricing.

Sirius XM was hemorrhaging money at that point. The satellite radio provider had just completed a potentially game-changing acquisition, but it was warning that it was on the brink of filing for bankruptcy reorganization. Sirius XM also blew up its outstanding share count in an mad-dash effort to raise money to stay afloat, just as Helios and Matheson is doing right now. MoviePass may be popular, but there are a few reasons why it's not the second coming of Sirius XM, a stock that would go on to become a scintillating 140-bagger after bottoming out at a nickel.

MoviePass and iHeartRadio at a promotional event in March.

Image source: MoviePass.

1. Sirius XM got a life-changing capital infusion

Sirius XM was running out of money, but it had a pair of media moguls willing to step up with a financial lifeline. Sirius XM chose to go with John Malone's offer. Sirius XM was desperate. It handed Malone a 40% preferred share stake in exchange for a $530 million loan that it would have to repay at 15% interest.�

It wasn't pretty -- and it was another step in dramatically expanding the share count -- but it was what Sirius XM needed at the time. The problem with Helios and Matheson is that there aren't a lot of sugar daddies likely waiting in the wings.�

A multiplex operator isn't going to step up because MoviePass devalues their product. With 3 million premium subscribers, MoviePass has value, but likely not enough to drum up the interest from acquirers that could actually make the most of the MoviePass platform. Even if there was a company with deep pockets eager to help, the model itself could be a deal breaker.�

2. Sirius XM turned profitable�

Sirius XM was able to post positive net income within a couple of quarters of bottoming out, and it's pretty much been that way ever since. There is no reason to believe that MoviePass will be profitable anytime soon.

Sirius XM operates a model where the fixed income costs are high but the variable rates are low. Once it hit a point where scalability would kick in, it was easy to see where the bottom line would grow exponentially. MoviePass is the other way around. The company pays retail prices for most of the movie tickets it subsidizes, so it spends a lot more than $9.95 a month on tickets. Variable costs are high, and gross margin will continue to be negative at current price points.�

Sirius XM had a compelling business model, and that made it easy to raise money. Helios and Matheson won't be so lucky.

3. MoviePass doesn't have pricing elasticity

Sirius XM has been able to consistently grow its subscriber count, and that's with the music royalty fees that it passes on to listeners inching higher with every passing year. MoviePass is going to be a hard sell outside of $9.95 a month. There were just 20,000 subscribers last summer when the service cost most accounts $29.95 a month. The spike to 3 million has come as a result of the value proposition.�

It's not a sustainable value proposition for MoviePass, and it's rolling out surge pricing -- making folks pay a bit more to view movies during peak levels. This could be the beginning of the end for MoviePass, and it comes at a time when actual exhibitors -- the multiplix operators that can actually turn a profit by discounting ticket sales -- are�beefing up their rival offerings.�

MoviePass is in a pickle. If it raises its price it will lose subscribers, particularly the light users that it needs to offset the heavy eaters of its celluloid buffet. Adding new fees and restrictive conditions will have the same effect.�

Sirius XM and MoviePass are entertainment subscription services, but only one of them has shown the ability to offer its platform sustainably for the long haul. Helios and Matheson is going to need a model overhaul to stay afloat at this point.

Tuesday, July 10, 2018

Qiagen (QGEN) Getting Somewhat Positive Media Coverage, Analysis Finds

News coverage about Qiagen (NASDAQ:QGEN) has trended somewhat positive this week, according to Accern Sentiment. Accern ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Qiagen earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave media headlines about the company an impact score of 45.9679840450792 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Shares of NASDAQ:QGEN opened at $37.14 on Tuesday. Qiagen has a 1-year low of $30.20 and a 1-year high of $37.61. The company has a current ratio of 5.07, a quick ratio of 4.59 and a debt-to-equity ratio of 0.69.

Get Qiagen alerts:

Qiagen (NASDAQ:QGEN) last announced its quarterly earnings data on Wednesday, May 2nd. The company reported $0.26 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.24 by $0.02. The firm had revenue of $343.60 million during the quarter, compared to analysts’ expectations of $339.30 million. Qiagen had a return on equity of 11.74% and a net margin of 2.85%. The company’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.22 EPS. equities analysts expect that Qiagen will post 1.34 EPS for the current fiscal year.

A number of research analysts recently issued reports on QGEN shares. TheStreet raised Qiagen from a “c+” rating to a “b” rating in a report on Friday, May 25th. Commerzbank reaffirmed a “buy” rating on shares of Qiagen in a report on Thursday, May 3rd. BidaskClub raised Qiagen from a “hold” rating to a “buy” rating in a report on Thursday, May 3rd. Deutsche Bank reaffirmed a “buy” rating and issued a price target (up from ) on shares of Qiagen in a report on Tuesday, April 24th. Finally, Goldman Sachs Group reaffirmed a “buy” rating on shares of Qiagen in a report on Wednesday, May 16th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have issued a buy rating to the stock. Qiagen presently has a consensus rating of “Hold” and a consensus price target of $35.55.

Qiagen Company Profile

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials.

Insider Buying and Selling by Quarter for Qiagen (NASDAQ:QGEN)

Saturday, July 7, 2018

Analysts Anticipate Fennec Pharmaceuticals Inc (FENC) to Announce ($0.10) EPS

Fennec Pharmaceuticals Inc (NASDAQ:FENC) has received an average broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the company, Zacks Investment Research reports. Two investment analysts have rated the stock with a strong buy rating.

Analysts have set a 1 year consensus price target of $17.50 for the company and are expecting that the company will post ($0.10) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Fennec Pharmaceuticals an industry rank of 162 out of 255 based on the ratings given to related companies.

Get Fennec Pharmaceuticals alerts:

Several research firms recently issued reports on FENC. HC Wainwright reissued a “buy” rating and issued a $18.00 price target on shares of Fennec Pharmaceuticals in a research report on Wednesday, June 20th. Zacks Investment Research lowered shares of Fennec Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Wednesday, May 30th. ValuEngine raised shares of Fennec Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, May 17th. Finally, Wedbush began coverage on shares of Fennec Pharmaceuticals in a research report on Monday, March 12th. They issued an “outperform” rating and a $17.00 price target for the company.

Fennec Pharmaceuticals traded down $0.48, hitting $10.35, during mid-day trading on Friday, MarketBeat reports. The company’s stock had a trading volume of 134,706 shares, compared to its average volume of 78,135. Fennec Pharmaceuticals has a fifty-two week low of $7.55 and a fifty-two week high of $14.99. The firm has a market capitalization of $195.82 million, a PE ratio of -22.89 and a beta of -0.24.

Fennec Pharmaceuticals (NASDAQ:FENC) last posted its quarterly earnings results on Monday, May 14th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. equities research analysts expect that Fennec Pharmaceuticals will post -0.41 earnings per share for the current fiscal year.

A hedge fund recently raised its stake in Fennec Pharmaceuticals stock. Opaleye Management Inc. grew its position in shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) by 3.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 873,000 shares of the company’s stock after buying an additional 26,100 shares during the quarter. Fennec Pharmaceuticals makes up about 3.0% of Opaleye Management Inc.’s investment portfolio, making the stock its 9th biggest position. Opaleye Management Inc. owned 4.72% of Fennec Pharmaceuticals worth $10,559,000 at the end of the most recent reporting period. 41.05% of the stock is currently owned by institutional investors and hedge funds.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc, a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children.

Get a free copy of the Zacks research report on Fennec Pharmaceuticals (FENC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Friday, July 6, 2018

Analysts Expect Ascena Retail Group Inc (ASNA) to Post $0.04 Earnings Per Share

Brokerages predict that Ascena Retail Group Inc (NASDAQ:ASNA) will post earnings per share (EPS) of $0.04 for the current quarter, according to Zacks. Two analysts have made estimates for Ascena Retail Group’s earnings. The lowest EPS estimate is $0.03 and the highest is $0.04. Ascena Retail Group reported earnings of $0.05 per share during the same quarter last year, which indicates a negative year over year growth rate of 20%. The company is scheduled to issue its next earnings results on Monday, September 24th.

Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that cover Ascena Retail Group.

Get Ascena Retail Group alerts:

Ascena Retail Group (NASDAQ:ASNA) last announced its quarterly earnings results on Wednesday, June 6th. The specialty retailer reported ($0.08) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.01. Ascena Retail Group had a negative net margin of 1.37% and a negative return on equity of 1.08%. The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter last year, the firm earned $0.05 EPS. The firm’s revenue for the quarter was down 3.9% compared to the same quarter last year.

ASNA has been the topic of a number of recent analyst reports. BidaskClub lowered shares of Ascena Retail Group from a “buy” rating to a “hold” rating in a research report on Friday, April 20th. ValuEngine lowered shares of Ascena Retail Group from a “hold” rating to a “sell” rating in a research report on Friday, March 9th. B. Riley reduced their price objective on shares of Ascena Retail Group from $2.50 to $2.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 6th. Finally, Zacks Investment Research raised shares of Ascena Retail Group from a “hold” rating to a “buy” rating and set a $4.00 price objective on the stock in a research report on Tuesday, June 5th. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $3.38.

Ascena Retail Group traded down $0.27, reaching $3.79, during midday trading on Wednesday, MarketBeat Ratings reports. The stock had a trading volume of 1,783,053 shares, compared to its average volume of 4,620,369. The company has a debt-to-equity ratio of 1.91, a current ratio of 1.28 and a quick ratio of 0.57. Ascena Retail Group has a 52-week low of $1.69 and a 52-week high of $4.74. The firm has a market capitalization of $796.63 million, a P/E ratio of 17.23 and a beta of 1.75.

Institutional investors have recently bought and sold shares of the stock. Teacher Retirement System of Texas raised its position in Ascena Retail Group by 298.9% in the 4th quarter. Teacher Retirement System of Texas now owns 49,225 shares of the specialty retailer’s stock worth $116,000 after purchasing an additional 36,884 shares during the period. Jane Street Group LLC increased its position in shares of Ascena Retail Group by 384.8% during the first quarter. Jane Street Group LLC now owns 55,647 shares of the specialty retailer’s stock worth $112,000 after acquiring an additional 44,168 shares during the period. Stone Ridge Asset Management LLC purchased a new position in shares of Ascena Retail Group during the fourth quarter worth approximately $181,000. MetLife Investment Advisors LLC increased its position in shares of Ascena Retail Group by 201.0% during the first quarter. MetLife Investment Advisors LLC now owns 84,485 shares of the specialty retailer’s stock worth $170,000 after acquiring an additional 56,415 shares during the period. Finally, Wedge Capital Management L L P NC increased its position in shares of Ascena Retail Group by 28.6% during the first quarter. Wedge Capital Management L L P NC now owns 136,858 shares of the specialty retailer’s stock worth $275,000 after acquiring an additional 30,417 shares during the period. 92.32% of the stock is currently owned by institutional investors.

Ascena Retail Group Company Profile

Ascena Retail Group, Inc, through its subsidiaries, operates as a specialty retailer of apparel, shoes, and accessories for women and tween girls in the United States, Canada, and Puerto Rico. The company operates through six segments: ANN, Justice, Lane Bryant, maurices, dressbarn, and Catherines. It creates, designs, and develops a range of merchandise, including apparel, accessories, footwear, and intimates; lifestyle products comprising cosmetics and bedroom furnishings; and wear-to-work, sportswear, footwear, and social occasion apparel.

Get a free copy of the Zacks research report on Ascena Retail Group (ASNA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ascena Retail Group (NASDAQ:ASNA)

Monday, June 25, 2018

4 Social Security myths and why they're wrong

Once again, there's dire news about Social Security. Its trustees claim in their 2018 report that�they must tap the program's sacred "Trust Funds"�to cover this year��s benefits. And they warn that the funds�will be depleted by 2034, forcing steep benefit�cuts, unless Congress fixes things. Scary.

And wrong.�Most Social Security fears rest�on myths. Here are four of the biggest �� and the reasons why they're�overblown.

Myth No. 1: If the funds run�out, today��s workers will never get what they put in.

Reality: As I wrote last December, the Social Security "trusts" aren't�in the ��lockbox�� of "Saturday Night Live" fame. It is a pay-as-you-go program. Your contributions pay current retirees. And when you retire, workers pay your benefits. The funds are�merely random accumulated surpluses from years when revenues happened to exceed benefits. This was never about retirees recouping contributions.

Myth No. 2: Tapping the trust funds�starts a spiral toward doom.

Reality: Actually, we��ve tapped them�before. In 1982, Social Security ��borrowed�� from the Disability Insurance Trust and Medicare Trust to pay all retirement benefits. The trustees projected that wouldn��t work past mid-1983.

But 1982 was also the last time they tapped the trust fund, thanks to 1983��s Social Security reforms. The trust didn��t expire �� it accumulated a fat surplus over the next quarter century. Retirees got paid in full, on time. Tapping the fund prompted politicians to act and put in simple fixes.

Myth No. 3: Preserving Social Security requires huge tax hikes or benefit cuts.

Reality: In 1982, one alarmist warned paying full benefits would eventually require Social Security to collect 44 percent�of Americans�� annual earnings. Ouch! That never happened. Not even close.

Patching Social Security then merely required minor adjustments, partly to retirement age. Back then, combined Social Security taxes (payroll tax plus employee contributions) were 10.8 percent�of eligible income. Politicians simply accelerated a previously planned increase to 12.4 percent, today��s level. Meanwhile, the retirement age didn��t change for anyone born before 1938 ���folks over age 45 then. Changes for others were modest, from 65 to 66 for folks born up to 1955, and �� eventually �� 67 for those born in or after 1960. Those changes, along with making some Social Security benefits taxable plus several minor tweaks, covered everything for decades.

Congress could do something similar now. Minor tax increases staggered over the decades would do it. The Center on Budget and Policy Priorities estimates that raising�the combined tax rate to 14.8 percent�over the next 25 years would close two-thirds of the projected funding gap, costing workers an average additional $11.50 per week. Congress might also raise the cap on earnings eligible for Social Security taxes, currently $128,400. Congress initially made 90 percent�of total income eligible for Social Security taxes, but indexed it to average wage growth. Because incomes for folks above the cap outpaced this, more than one-third of workers�� income is now exempt. Raising the cap �� and the benefits cap in return �� could ease much of the shortfall. So could hiking millennials�� retirement age �� since they will surely live longer than earlier generations �� and adding incentives to delay benefits beyond age 70.


Myth No. 4: Social Security��s problems are part of a larger ��demographic crisis.��

Reality: This is only a ��problem�� because we��re living longer, healthier lives. In 1940, five years after Social Security��s birth, the average 65-year-old man and woman had 12.7 and 14.7 years left, respectively. Those last years were difficult after lifetimes spent working at physically demanding jobs. Today? Average life expectancy at 65 is another 18 years for men and 20.6 for women. It��ll get even longer, as discussed in my Jan.�21 column. And that is great for Social Security��s future.�Full benefits kick in at 70. Having longer, healthy lives makes it easier to keep working in our services-driven economy until age 70 and beyond, boosting Social Security revenues for decades consistent with longer lives.

Ken Fisher is the founder and executive chairman of Fisher Investments, author of 11 books, four of which were "New York Times" bestsellers, and is No. 200 on the Forbes 400 list of richest Americans. Follow him on Twitter @KennethLFisher

The views and opinions expressed in this column are the author��s and do not necessarily reflect those of USA TODAY.

CLOSE

If you're planning on relying solely on your social security check for retirement, you may want to reconsider. Here's why. Wochit


Sunday, June 24, 2018

Head to Head Survey: Iteris (ITI) and UTStarcom (UTSI)

Iteris (NASDAQ: ITI) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

Volatility and Risk

Get Iteris alerts:

Iteris has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500. Comparatively, UTStarcom has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500.

Insider and Institutional Ownership

30.1% of Iteris shares are held by institutional investors. Comparatively, 26.5% of UTStarcom shares are held by institutional investors. 4.3% of Iteris shares are held by insiders. Comparatively, 2.7% of UTStarcom shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Iteris and UTStarcom, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Iteris 0 0 4 0 3.00
UTStarcom 0 0 1 0 3.00

Iteris presently has a consensus target price of $9.13, indicating a potential upside of 81.41%. UTStarcom has a consensus target price of $5.00, indicating a potential upside of 22.85%. Given Iteris’ higher probable upside, equities analysts plainly believe Iteris is more favorable than UTStarcom.

Profitability

This table compares Iteris and UTStarcom’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Iteris -3.40% -10.29% -6.52%
UTStarcom N/A N/A N/A

Valuation & Earnings

This table compares Iteris and UTStarcom’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Iteris $103.73 million 1.61 -$3.52 million ($0.04) -125.75
UTStarcom $98.29 million 1.47 $6.98 million N/A N/A

UTStarcom has lower revenue, but higher earnings than Iteris.

Summary

Iteris beats UTStarcom on 6 of the 11 factors compared between the two stocks.

Iteris Company Profile

Iteris, Inc. provides intelligent information solutions to traffic management and global agribusiness markets worldwide. It operates in three segments: Roadway Sensors, Transportation Systems, and Agriculture and Weather Analytics. The Roadway Sensors segment provides vehicle detection and information systems and products for traffic intersection control, incident detection, and roadway traffic data collection applications. Its products include Vantage detection system to detect vehicle presence at intersections, as well as vehicle count, speed, and other traffic data used in traffic management systems; Vantage Vector video/radar hybrid product, an vehicle detection sensor with capabilities, including stop bar detection, advanced-zone detection, and sensing; Vantage systems equipped with smartcycle capability to differentiate between bicycles and other vehicles with a single video detection camera; VersiCam, an integrated camera and processor video detection system; VantageLive!, a cloud-based subscription service; and SmartSpan, PedTrax ,Velocity, VantageLive, and P-series products. The Transportation Systems segment offers transportation engineering and consulting services with a focus on the planning, design, development, and implementation of software-based systems that integrate sensors, video surveillance systems, computers, and communications equipment to enable public agencies to monitor, control, and direct traffic flow; assist in the dispatch of emergency crews; and distribute real-time information about traffic conditions. It offers iPeMS, a specialized transportation performance measurement and traffic analytics solution. The Agriculture and Weather Analytics segment offers ClearPath Weather management tools that allow users to create solutions to meet roadway maintenance decision needs; and ClearAg, a precision agriculture solution. The company serves government agencies. Iteris, Inc. was founded in 1969 and is headquartered in Santa Ana, California.

UTStarcom Company Profile

UTStarcom Holdings Corp., together with its subsidiaries, operates as a telecom infrastructure provider to develop technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The company offers broadband packet optical transport and wireless/fixed-line access products and solutions. It focuses on delivering carrier-class broadband transport and access products and solutions optimized for mobile backhaul, metro aggregation, broadband access, Wi-Fi data, and value added services. The company provides optical transport products, such as packet transport network, next generation packet transport network, and SyncRing product lines that convert and translate data, video, voice, or other traffic into an optical signal that is transmitted over glass fiber; and SOO network (software-defined open packet optical) solution, which helps telecom operators to address the challenges related to the growth of mobile and cloud services, media streaming, and social networking, as well as new applications and services. It also offers carrier Wi-Fi products, such as solutions for managed wireless access networks, including wireless access controllers, VAS platforms, network management systems, and Wi-Fi access points for carrier and MSO markets, as well as various deployment scenarios; and a range of services, such as IPTV, high-speed Internet access, POTS, ISDN, VoIP, over twisted pair copper, and optical fiber. The company was founded in 1991 and is based in Admiralty, Hong Kong.

Tuesday, June 19, 2018

Cramer: US-China trade fight 'is not serious' right now; Trump has upper hand

CNBC's Jim Cramer said Tuesday that he's not worried yet about the escalating trade conflict between the United States and China.

"Right now, this is not serious," Cramer told "Squawk on the Street." "I'm waiting for something serious to hit my way."

The "Mad Money" host said the fight would get real if Apple, Yum China or Starbucks were targeted by boycotts or some other measure.

But for now, that's not happening, Cramer said, arguing President Donald Trump has the upper hand. "The president is saying, 'You know what guys [China] ... we got more staying power than you, particularly with your stock market collapse.'"

While the Dow Jones industrial average was off more than 300 points, or about 1.3 percent, in early Tuesday trading, the carnage in China was far worse.

"There were 1,000 stocks that were down 10 percent in China. Is that good for the Chinese? Are they sitting there saying, 'Let's have a real [trade war], bring it on?' No. They're going to have to support a lot of stock. It costs them a fortune," Cramer said.

The Shanghai and Shenzhen stock markets overnight dropped 3.8 percent and 5.77 percent, respectively, after Trump late Monday asked the U.S. trade representative to identify $200 billion worth of Chinese goods for additional tariffs at a rate of 10 percent.

That would be on top of the 25 percent import tariffs on up to $50 billion of Chinese products that Trump announced Friday. Those tariffs are set to start July 6. Chinese President Xi Jinping's administration has responded with 25 percent tariffs on $34 billion of U.S. goods.

Cramer said, "so what" to the argument that China could also start selling U.S. Treasurys as another way to get back at the U.S. "We could use a little inflection in the yield curve," he added.

WATCH: Cramer: Trump believes China is a paper tiger show chapters Cramer: Trump believes China is a paper tiger Cramer: Trump believes China is a paper tiger    2 Hours Ago | 03:27

Tuesday, May 29, 2018

$156.47 Million in Sales Expected for Prospect Capital Co. (PSEC) This Quarter

Equities analysts expect Prospect Capital Co. (NASDAQ:PSEC) to post $156.47 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Prospect Capital’s earnings. The highest sales estimate is $162.36 million and the lowest is $150.57 million. Prospect Capital reported sales of $166.70 million during the same quarter last year, which would suggest a negative year over year growth rate of 6.1%. The business is expected to report its next quarterly earnings results on Monday, August 27th.

According to Zacks, analysts expect that Prospect Capital will report full year sales of $634.09 million for the current fiscal year, with estimates ranging from $622.00 million to $646.18 million. For the next fiscal year, analysts anticipate that the company will post sales of $625.17 million per share, with estimates ranging from $602.00 million to $648.34 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that that provide coverage for Prospect Capital.

Get Prospect Capital alerts:

Prospect Capital (NASDAQ:PSEC) last issued its quarterly earnings results on Wednesday, May 9th. The financial services provider reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.01. Prospect Capital had a return on equity of 8.31% and a net margin of 36.39%. The company had revenue of $162.84 million for the quarter, compared to analysts’ expectations of $153.08 million. During the same period last year, the firm earned $0.20 EPS. The firm’s revenue for the quarter was down 4.8% on a year-over-year basis.

Several brokerages have recently issued reports on PSEC. BidaskClub upgraded Prospect Capital from a “sell” rating to a “hold” rating in a research report on Wednesday, March 21st. ValuEngine cut Prospect Capital from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd. National Securities reiterated a “sell” rating and set a $4.00 price target on shares of Prospect Capital in a research report on Monday, May 14th. Finally, Zacks Investment Research upgraded Prospect Capital from a “hold” rating to a “buy” rating and set a $7.50 price target on the stock in a research report on Tuesday, May 15th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $6.17.

Shares of Prospect Capital traded down $0.03, hitting $6.83, during mid-day trading on Friday, MarketBeat reports. 1,281,579 shares of the stock traded hands, compared to its average volume of 1,525,604. Prospect Capital has a twelve month low of $5.51 and a twelve month high of $8.40. The stock has a market cap of $2.48 billion, a PE ratio of 8.04 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.99 and a current ratio of 0.99.

The business also recently disclosed a monthly dividend, which will be paid on Thursday, September 20th. Stockholders of record on Friday, August 31st will be paid a dividend of $0.06 per share. This represents a $0.72 annualized dividend and a dividend yield of 10.54%. The ex-dividend date is Thursday, August 30th. Prospect Capital’s dividend payout ratio is presently 84.71%.

In related news, insider John F. Barry acquired 269,197 shares of Prospect Capital stock in a transaction dated Wednesday, February 28th. The stock was acquired at an average cost of $6.63 per share, with a total value of $1,784,776.11. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider John F. Barry acquired 4,483 shares of Prospect Capital stock in a transaction dated Wednesday, March 21st. The shares were bought at an average cost of $6.50 per share, with a total value of $29,139.50. Following the completion of the purchase, the insider now owns 34,413,790 shares in the company, valued at $223,689,635. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 443,224 shares of company stock valued at $2,915,694. Corporate insiders own 7.10% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sumitomo Mitsui Asset Management Company LTD bought a new stake in shares of Prospect Capital during the 4th quarter worth $2,544,000. Virtu Financial LLC boosted its stake in shares of Prospect Capital by 302.9% during the 4th quarter. Virtu Financial LLC now owns 294,330 shares of the financial services provider’s stock worth $1,984,000 after acquiring an additional 221,274 shares in the last quarter. Eqis Capital Management Inc. boosted its stake in shares of Prospect Capital by 266.2% during the 4th quarter. Eqis Capital Management Inc. now owns 438,826 shares of the financial services provider’s stock worth $2,958,000 after acquiring an additional 319,001 shares in the last quarter. Prime Capital Investment Advisors LLC bought a new stake in shares of Prospect Capital during the 4th quarter worth $130,000. Finally, Aperio Group LLC boosted its stake in shares of Prospect Capital by 51.6% during the 4th quarter. Aperio Group LLC now owns 62,741 shares of the financial services provider’s stock worth $423,000 after acquiring an additional 21,357 shares in the last quarter. 12.73% of the stock is owned by institutional investors and hedge funds.

About Prospect Capital

Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, subordinated debt tranches of collateralized loan obligations, cash flow term loans, and bridge transactions.

Get a free copy of the Zacks research report on Prospect Capital (PSEC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Monday, May 28, 2018

3 Healthcare Stocks That Are Undeniably Dirt Cheap Right Now

Even in the midst of a market that many view as overpriced, inexpensive stocks can be found. One valuation metric that I like to use to find these potential bargains is the enterprise value-to-EBITDA ratio.

The first component of this metric -- enterprise value (EV) -- is calculated by adding market cap plus debt, minority interest, and preferred shares, then subtracting total cash and cash equivalents. EV represents what it would actually cost to buy a company outright, which makes it more useful than just market cap or stock price.

The second component of the metric is EBITDA -- earnings before interest, taxes, depreciation, and amortization. One advantage to using EBITDA instead of net income is that it isn't affected by how a company finances its balance sheet (for example, through debt, issuing equity, or both).

A low EV-to-EBITDA measurement is a pretty good indicator that a stock is relatively cheap. And there are three healthcare stocks that are undeniably dirt cheap right now based on the metric: United Therapeutics (NASDAQ:UTHR), Gilead Sciences (NASDAQ:GILD), and Humana (NYSE:HUM). But are these cheap stocks smart picks to buy?

Businessman touching screen displaying heartbeat line and dollar symbol

Image source: Getty Images.

1. United Therapeutics

United Therapeutics claims a super-low EV-to-EBITDA ratio of 3.98. You won't find many stocks that are less expensive using the metric. But why is the biotech so cheaply priced?

A lot of United Therapeutics' low valuation stems from the threats the company faces from generic competition. Pulmonary arterial hypertension (PAH) drugs Remodulin and Adcirca generated $671 million and $420 million in sales, respectively, in 2017. Revenue from these drugs will probably fall with generic versions�likely to reach the market this summer.�

The biotech does have three other approved drugs -- Tyvaso, Orenitram, and Unituxin. However, these drugs combined contributed less than 37% of United Therapeutics' total revenue last year. Also, the patents for Tyvaso are being challenged by a leading generic-drug maker.�

United Therapeutics' pipeline includes seven candidates that could win approval over the next three years. Five of these candidates are new formulations or combinations of the company's existing drugs. It remains to be seen if these drugs can turn things around for United Therapeutics.��

2. Gilead Sciences

Gilead Sciences' EV-to-EBITDA ratio currently stands at 6.39. This value is well below that of other big biotechs in Gilead's peer group. As is the case with United Therapeutics, though, there's an easily identifiable reason behind Gilead's low valuation.

For Gilead, that reason is sinking hepatitis C virus (HCV) product sales. The biotech once enjoyed staggering growth, thanks to its HCV franchise. Gilead is largely a victim of its own success, though. So many patients were cured that there are fewer patients remaining who need treatment. In addition, Gilead now has a formidable rival in the HCV market with AbbVie.

Despite these HCV woes, however, there are several reasons to think that the future could be brighter for Gilead. The biotech's management team thinks that HCV sales will stabilize. Gilead recently launched new HIV drug Biktarvy, which is practically a sure bet for becoming a megablockbuster success.�

The company's pipeline could also help Gilead's fortunes improve in the not-too-distant future. Two candidates that especially stand out are selonsertib, which targets treatment of non-alcoholic steatohepatitis (NASH), and autoimmune disease drug filgotinib.�

3. Humana

Humana claims an EV-to-EBITDA ratio of 6.97. The big health insurer's main rivals are much more expensive. The primary reason behind Humana's relatively low valuation can be found on its balance sheet.

While Humana's market cap is around $40 billion, the company's enterprise value is less than $26 billion. Why this big gap? Humana's cash stockpile, including cash, cash equivalents, and marketable securities, totaled $18.6 billion at the end of the first quarter. The company's total debt was only $5.3 billion.

At least one deep-pocketed investor seems to find Humana's valuation attractive. The Wall Street Journal reported last month that Walmart�was in early talks about acquiring Humana. There are several reasons the huge retail company could be interested in moving into health insurance. So far, though, no final deal has been announced.

Even if Walmart doesn't buy Humana, the health insurer appears to be in solid shape. Humana's Medicare Advantage business is booming. After posting great Q1 results earlier this month, the company upped its full-year 2018 earnings guidance.��

But are they buys?

Just because something is cheap doesn't mean you should buy it. Sometimes, the low valuation should instead be a warning sign to stay away.

I think that's the case with one of these stocks. United Therapeutics faces huge challenges that I suspect will cause its stock to drop even more.�However, my view is that it's a different story for Gilead Sciences and Humana.

The ingredients are there for Gilead to make a comeback. I think that stabilization in the company's HCV sales is a matter of when -- rather than if. I like the prospects for Biktarvy and for Gilead's pipeline.�I also like Humana's position in the marketplace. An acquisition by Walmart seems like a smart move in my opinion.�

All three of these healthcare stocks are cheap for a reason. But I predict that Gilead and Humana will only be cheap for a season.

Friday, May 25, 2018

Trader-Based Social Network TradingView Raises $37 Million In Series B Funding

TradingView, winner of Best Analysis Tool at Benzinga’s 2017 Fintech Awards, announced Monday that it closed a $37-million round of Series B financing meant to expand its software suite and international reach.

The seven-year-old company operates one of the market’s largest financial and social platforms meant to democratize trading among self-directed investors.

With more cash on hand, TradingView intends to expand over the next six to 12 months by:

Moving its headquarters to the financial hub of New York; Expanding charting and analytics data with the potential addition of options; Adding more U.S. and international brokers, such as Robinhood, E*TRADE Financial Corp (NADSAQ: ETFC) and TD Ameritrade Holding Corp. (NASDAQ: AMTD); Incorporating big crypto exchanges; and Building out mobile and app platforms.

It also plans to improve international interactions.

"There's a lot of things to be done in terms of visibility in each region," TradingView COO Stan Bokov told Benzinga. "China is huge in the trading world, and it requires Weibo, QQ and Alipay integrations, etc. so we'll be focusing a lot on local needs, what kind of news they need, data, experience, pricing, etc."

TradingView's products appeal largely to millennials but also support institutional clients such as CME Group, Investopedia, Zacks and national exchanges.

"TradingView has clearly emerged as the preeminent charting platform and social network for active traders," Peter Johnson, vice president at Jump Capital, said in a press release. "Their tools have become an invaluable resource to the trading community, as demonstrated by their rapid growth to over 8 million monthly users and integrations into thousands of leading exchanges and financial applications."

In its early days, TradingView got a boost from TechStars Chicago and secured $3.7 million from TechStars, Irish Angels, iTech Capital and other angel investors. Its latest round of financing was led by Insight Venture Partners with contributions from Jump Capital and DRW Venture Capital.

Related Links:

'Trading Is The Ultimate Goal': Fintech Is Dictating The Development Of Cryptocurrency

For Traders, The Right Charting Software Is Critical

Photo courtesy of TradingView.

Thursday, May 24, 2018

Qatari Lender Closes Gap on Abu Dhabi Rival in Mideast Shuffle

Qatar National Bank QPSC is no longer being punished for a boycott imposed on the country by some of its neighbors as this month’s MSCI Inc. weighting change draws passive inflows to the stock.

A 36 percent rally spurred by the decision to raise the foreign ownership limit in March means QNB now trades at a similar valuation to First Abu Dhabi Bank PJSC for the first time in more than a year. FAB had become one of the shares of choice in the United Arab Emirates after a deal that created the country’s biggest lender last year.

The estimated price-to-earnings ratio for the Emirati bank has slipped to 10.3, matching the level for QNB, the dominant stock in Qatar’s benchmark index.

#lazy-img-327988858:before{padding-top:56.25%;}

QNB and FAB are “the two biggest single security index trades” for 2018 in the Middle East and North Africa, according to Mohamad Al Hajj, an equities strategist at the research arm of EFG-Hermes Holding in Dubai.

The Qatari lender could lure inflows of $651 million after the index re-balancing, which was triggered by the country increasing the maximum foreigners can hold to 49 percent, he estimates. FAB could attract more than $300 million in passive flows after a review of its weighting in the same index, expected to be announced in November, he said.

The Abu-Dhabi based bank is the result of the merger of First Gulf Bank PJSC and National Bank of Abu Dhabi PJSC, which at completion had created a financial giant with $180 billion in assets under management.

The Emirati lender remains an interesting play following the stock’s recent dip, especially considering the “value that will be generated by the merger,” said Ali El Adou, the head of asset management at Daman Investments in Dubai.

FAB rose 4.3 percent, the most in more than a year, at the close in Abu Dhabi on Wednesday, while QNB slipped 0.1 percent in Doha. They have a market valuation of $36 billion and $40 billion, respectively.

LISTEN TO ARTICLE 1:57 Share Share on Facebook Post to Twitter Send as an Email Print

Wednesday, May 23, 2018

Sell Apollo Hospitals, target Rs 890: Vinay Rajani

Vinay Rajani

The pharma and healthcare sector has been underperforming for the last 3 years and the Nifty Pharma index has reached its new 52-week low recently.

Apollo Hospitals has also been showing weakness on the short to medium term charts. On the weekly charts, the stock has confirmed breakdown from its bearish head and shoulder pattern.

The stock is currently trading below 50, 100 and 200-DMA, indicating a bearish trend on all time frames. Oscillators like RSI, MACD, and DMI have been showing weakness on the charts.

We recommend selling Apollo Hospitals for the downside target of Rs 890, and keeping a stop loss above Rs 1,050.

Disclaimer: The author is Technical Analyst, PCG Desk, HDFC Securities. The views and investment tips expressed by investment expert on moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Sunday, May 20, 2018

Insider Selling: Reliant Bancorp (RBNC) Director Sells $73,260.00 in Stock

Reliant Bancorp (NASDAQ:RBNC) Director William Ronald Deberry sold 3,000 shares of the business’s stock in a transaction dated Wednesday, May 16th. The shares were sold at an average price of $24.42, for a total transaction of $73,260.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

William Ronald Deberry also recently made the following trade(s):

Get Reliant Bancorp alerts: On Friday, May 18th, William Ronald Deberry sold 1,085 shares of Reliant Bancorp stock. The stock was sold at an average price of $25.00, for a total transaction of $27,125.00.

NASDAQ RBNC traded up $0.14 on Friday, hitting $25.13. The stock had a trading volume of 10,929 shares, compared to its average volume of 8,291. Reliant Bancorp has a one year low of $21.42 and a one year high of $27.49. The company has a current ratio of 0.85, a quick ratio of 0.80 and a debt-to-equity ratio of 0.06. The stock has a market cap of $288.52 million, a price-to-earnings ratio of 22.44 and a beta of 0.32.

Reliant Bancorp (NASDAQ:RBNC) last posted its earnings results on Thursday, April 26th. The bank reported $0.33 EPS for the quarter. Reliant Bancorp had a net margin of 16.11% and a return on equity of 7.04%. The firm had revenue of $16.37 million during the quarter.

The company also recently announced a quarterly dividend, which was paid on Friday, April 20th. Shareholders of record on Tuesday, April 10th were given a $0.08 dividend. This is a boost from Reliant Bancorp’s previous quarterly dividend of $0.06. The ex-dividend date was Monday, April 9th. This represents a $0.32 annualized dividend and a yield of 1.27%.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Patten Group Inc. grew its position in Reliant Bancorp by 30.4% in the 1st quarter. Patten Group Inc. now owns 10,729 shares of the bank’s stock worth $245,000 after purchasing an additional 2,502 shares during the last quarter. American International Group Inc. bought a new position in Reliant Bancorp in the 1st quarter worth about $101,000. New York State Common Retirement Fund bought a new position in Reliant Bancorp in the 1st quarter worth about $169,000. California State Teachers Retirement System bought a new position in Reliant Bancorp in the 1st quarter worth about $241,000. Finally, Schwab Charles Investment Management Inc. bought a new position in Reliant Bancorp in the 1st quarter worth about $267,000. Hedge funds and other institutional investors own 22.10% of the company’s stock.

About Reliant Bancorp

Reliant Bancorp, Inc operates as the holding company for Reliant Bank that provides a range of commercial banking services for businesses and individuals in the Middle Tennessee region and the Nashville-Davidson-Murfreesboro-Franklin Metropolitan Statistical Area. Its deposit products include checking, savings, and money market deposit accounts; time deposits; certificates of deposit; and non-interest-bearing and interest bearing demand deposits.